Tingting Liu, Yueqin Xu, Qingwei Wang, Shiya Yu, Hongming Lin, Zeyi Ye, Zhiqiang Zheng, Changan Yang, Tianzi Hong
{"title":"Primary Mammary Angiosarcoma in a Postmenopausal Woman: A Case Report","authors":"Tingting Liu, Yueqin Xu, Qingwei Wang, Shiya Yu, Hongming Lin, Zeyi Ye, Zhiqiang Zheng, Changan Yang, Tianzi Hong","doi":"10.1002/cnr2.70653","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Primary breast angiosarcoma (PAS) is a rare aggressive mesenchymal breast tumor, which predominantly affects young premenopausal women and is prone to misdiagnosis due to nonspecific clinical and imaging features. Surgical resection is the main treatment, while the efficacy of adjuvant chemoradiotherapy remains unclear. Targeted therapy represents a promising novel therapeutic direction.</p>\n </section>\n \n <section>\n \n <h3> Case</h3>\n \n <p>A 51-year-old postmenopausal woman presented with a rapidly enlarging left breast mass for over 3 months. Physical examination showed a 4 cm × 3 cm × 2 cm mass with a smooth surface, moderate mobility and no cutaneous changes. The lesion was radically resected via two-stage surgery, and the patient was diagnosed with stage I (T1N0M0) primary left breast angiosarcoma. The patient received sequential adjuvant chemotherapy with doxorubicin plus cyclophosphamide followed by paclitaxel. No recurrence or metastasis occurred during more than 5 years of follow-up.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Different from conventional PAS predominantly occurring in young women, this atypical postmenopausal PAS has high concealment and diagnostic difficulty. This study summarizes the clinical characteristics and diagnostic pitfalls of this rare case, supplements the clinical and prognostic data of postmenopausal PAS, and helps improve clinicians' recognition of atypical PAS to avoid delayed diagnosis and treatment.</p>\n </section>\n </div>","PeriodicalId":9440,"journal":{"name":"Cancer reports","volume":"9 9","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2026-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cnr2.70653","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cnr2.70653","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Primary breast angiosarcoma (PAS) is a rare aggressive mesenchymal breast tumor, which predominantly affects young premenopausal women and is prone to misdiagnosis due to nonspecific clinical and imaging features. Surgical resection is the main treatment, while the efficacy of adjuvant chemoradiotherapy remains unclear. Targeted therapy represents a promising novel therapeutic direction.
Case
A 51-year-old postmenopausal woman presented with a rapidly enlarging left breast mass for over 3 months. Physical examination showed a 4 cm × 3 cm × 2 cm mass with a smooth surface, moderate mobility and no cutaneous changes. The lesion was radically resected via two-stage surgery, and the patient was diagnosed with stage I (T1N0M0) primary left breast angiosarcoma. The patient received sequential adjuvant chemotherapy with doxorubicin plus cyclophosphamide followed by paclitaxel. No recurrence or metastasis occurred during more than 5 years of follow-up.
Conclusion
Different from conventional PAS predominantly occurring in young women, this atypical postmenopausal PAS has high concealment and diagnostic difficulty. This study summarizes the clinical characteristics and diagnostic pitfalls of this rare case, supplements the clinical and prognostic data of postmenopausal PAS, and helps improve clinicians' recognition of atypical PAS to avoid delayed diagnosis and treatment.
背景:原发性乳腺血管肉瘤(Primary breast angiosarcoma, PAS)是一种罕见的侵袭性乳腺间充质肿瘤,主要发生在年轻绝经前妇女,由于临床和影像学特征不明确,易误诊。手术切除是主要治疗方法,辅助放化疗的疗效尚不清楚。靶向治疗是一个很有前景的治疗新方向。病例:51岁绝经后妇女,左乳肿块迅速增大3个多月。体格检查显示一个4 cm × 3 cm × 2 cm的肿块,表面光滑,活动适中,无皮肤改变。通过两期手术彻底切除病变,患者被诊断为I期(T1N0M0)原发性左乳血管肉瘤。患者接受阿霉素加环磷酰胺序贯辅助化疗,再辅以紫杉醇。随访5年以上无复发或转移。结论:与以年轻女性为主的传统PAS不同,这种不典型绝经后PAS具有较高的隐蔽性和诊断难度。本研究总结了该罕见病例的临床特点及诊断误区,补充了绝经后PAS的临床及预后资料,有助于提高临床医生对非典型PAS的认识,避免延误诊断和治疗。